Improving Oncology Patients' Care: A portal for Health Care Professionals

eScientiq is a unique portal that augments medical research materials for Health Care Professionals (HCPs) specializing in oncology. It's a continually evolving research-centric platform with clinical care integrations, providing key health updates and revolutionizing patient-centric care. The platform facilitates strategic research consensus, real-time discussions, and participation in global and independent treatment surveys, offering HCPs opportunities for collaboration, idea generation, and accessing current medical research.

What we do?

Medical Education
‍

eScientiq offers a versatile platform catering to the needs of medical scientists and healthcare providers by providing them with access to cutting-edge medical advancements, facilitating license renewal, providing pivotal healthcare training, and offering a comprehensive repertoire of educational content

Consensus on treatment practise

eScientiq empowers foremost specialists, HCPs, medical oncologists, pathologists, pharmacists, and other accomplished members of multidisciplinary teams to engage in profound discourse, reach a consensus, and concur on the most effective treatment options for the most intricate oncological cases

Surveys across medical professionals

With eScientiq, the team members possess the capability to commence and execute surveys whilst also allowing for participation in said surveys. Additionally, it allows provisions for publication of survey results in multiple reputable scientific journals

Trending CMEs

April - September 2024

Chronic Lymphocytic Leukemia CLL Educational Program
‍

This project aims to inform attendees about the difference between covalent and non-covalent BTKis; mechanism of BTKi resistance; coping with the resistance; management of CLL patients; managing side effects of BTKis; choosing between different BTKis; clinical trials and results; and diagnosis and treatment of Richter Syndrome.

April 5th, 2024, 11:30 AM - 12:30 PM ET

Webinar 1. Resistance of BTK Inhibitors in treating Chronic Lymphocytic Leukemia

Explore cutting-edge insights in targeted therapies for CLL patients, from covalent to noncovalent BTK inhibitors. Delve into genetic mechanisms of resistance and the intricate BCR signaling pathway. Uncover new biomarkers and mechanisms driving resistance development, even in patients lacking genetic variations.

May 7th, 2024, 1 PM ET

Webinar 2. Resistance of BTK Inhibitors: Identifying Risk Factors and Diagnostics

CLLever’s dedication is unwavering - this session embarks on an exhilarating realm of contemporary and future of Chronic Lymphocytic Leukemia (CLL).
Our aim is resolute: to divulge information on BTK resistance in treating CLL to revolutionize patient outcomes.

June 21st 2024 at 3pm ET

Webinar 3. CLL Patients’ Management: Treatment of High Risk or Relapsed CLL

Delve deeper into management of High Risk or Relapsed CLL patients. Venture into the treatment landscape of CLL in high-risk and relapsed setting and evaluation of abandoning of immunochemotherapy in first line treatment.

September 11th at 11 AM

Webinar 4: Risk Factors, Molecular Pathogenesis, and Prognosis of Richter Syndrome

Discover the details about risk factors, molecular pathogenesis, and prognosis of Richter Syndrome. Learn about the current approaches to proper management of Richter Syndrome.

October 31, 2024 at 10am ET

Webinar 5: Long-term safety of CLL treatment – Management of Risks

Explore the long-term safety of CLL and ascertain how do you choose the right option. Get informed about "How to discuss treatment discontinuation with your patients?"

August 15, 2024

Webinar 1: HR+/ HER2- mBreast Cancer management
‍

Get insights about participants' clinical practice and informed about gaps and needs in clinical practice.

August 29, 2024

Webinar 2: Novel treatment strategies for HR+/ HER2- mBreast Cancer

Receive updates on current treatment landscape and unmet needs; Explore mechanisms of resistance and its management; Discuss treatment strategies.

September 5, 2024

Webinar 3: Biomarkers are the guide to make treatment decisions

Build awareness on current biomarker testing and establish the role of biomarker testing in treatment strategies; Non-pathologists will learn how to implement in practice.

September 19, 2024

Webinar 4: Adverse events management

Analyze AEs in BC management and approaches to overcoming them; Understand their role in decision making.

Current Projects

Get further informed about challenges and obstacles in treating HR+/HER2- mBC patients through a poster session at SABCS 2024 on December 11, 2024 from 5:30pm to 7:00pm at the Henry B. Gonzalez Convention Center, San Antonio, Texas.

‍
Real-World Treatment Challenges in HR+/HER2- mBC: Results from the RETRACT Survey of 150 US Oncologists
‍Authors: Hope Rugo, Aditya Bardia, William Gradishar, Erika Hamilton, Sara Hurvitz, Komal Jhaveri, Reshma Mahtani, Sara Tolaney

‍

Our Mission

‍We are on a mission to improve physicians’ competencies such as medical knowledge in the oncology space by organizing and delivering educational events, expert forums, and networking opportunities by capitalizing on eScientiq, a unique and versatile digital platform.

Our medical education events enable clinicians to access state-of-the-art knowledge and to interact with leading oncology experts with the goal of fostering evidence-based practice with a focus on patient-centered care and interdisciplinary teamwork to improve patient quality of life, functional status, and ultimately prolong their survival.

Key focus areas

Our digital platform enables Health Care Professionals to connect, correspond, and engage with global oncology specialists and care givers in key focus areas

Lung Cancer

eScientiq provides medical research materials, updates, and discussions related to lung cancer. Health care professionals specializing in oncology can access this information on the platform to augment their understanding, improve patient care, and engage with global oncology specialists and caregivers in this area.

Rare Cancer

eScientiq offers a unique portal for parsing core medical research materials and content related to rare cancers. Health care professionals can access and utilize this specialized information to enhance their knowledge, treatment strategies, and patient care in the context of rare cancer types.

Breast Cancer

eScientiq's digital platform focuses on breast cancer by providing medical professionals with access to relevant research materials and updates. It facilitates connections and correspondence with global oncology specialists, enabling health care professionals to stay up to date with the latest advancements and consensus on breast cancer treatment practices.

eScientiq serves as a portal for health care professionals to access and parse medical research materials, clinical care integrations, and discussions related to GI cancers. This enables professionals to connect with global oncology specialists and caregivers and stay informed about the latest updates and advancements in the diagnosis and treatment of gastrointestinal cancers.

The eScientiq platform caters to health care professionals specializing in GU cancers by providing research materials, clinical care integrations, and discussions related to this specific cancer type. It facilitates connections, consensus-building, and knowledge exchange among professionals, enhancing their ability to access key updates and advancements in the field of genitourinary cancers.

OncoHematology

eScientiq's platform supports health care professionals in the field of OncoHematology by providing access to research materials, clinical care integrations, and real-time discussions. This allows professionals to stay updated with the latest advancements and treatment practices specific to hematological malignancies, facilitating improved patient care in this specialized area of oncology.